| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2016-03-14 15:50:52 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm holds Investor Conference Webinar about financial results of 2015AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on March 14, 2016 at 16:00 (EET). To join the webinar please follow the instructions below. Webinar is hosted by the Member of the Management Board Salvis Lapiņš. The presentation is held in English. Salvis Lapiņš informs about AS “Olainfarm” latest activities and analyzes the financial results of the fourth quarter 2015 and non-audited financial results of 12 months 2015. After the presentation investors are welcome to ask questions. During the webinar the enclosed presentation is being presented.
What is webinar?
How to join the webinar? To join the webinar, we invite you to register via ej.uz/OLF_YE2015.
You will be provided with the webinar link and instructions to join
webinar successfully. When joining the webinar for the first time,
you will be asked to download the system application on your
computer which will take only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by: |
| Pielikumi |